Literature DB >> 12869503

Scaffold attachment region-containing retrovirus vectors improve long-term proviral expression after transplantation of GFP-modified CD34+ baboon repopulating cells.

Peter Kurre1, Julia Morris, Bobbie Thomasson, Donald B Kohn, Hans-Peter Kiem.   

Abstract

Sustained high-level proviral expression is important for clinical applications of gene therapy. Genetic elements including the beta-interferon scaffold attachment region (SAR) have been shown to improve transgene expression in hematopoietic cells. We hypothesized that SAR elements might improve expression and allow the preselection of successfully transduced cells. Thus, we transplanted green fluorescent protein (GFP)-selected cells, half of which had been transduced with either SAR or non-SAR-containing retrovirus vectors, into 3 animals. All animals showed delayed engraftment compared with historic controls (28 vs 15.5 days). GFP marking was seen at levels up to 8% but declined over the first 6 weeks. Importantly, fluorescence intensity was 2- to 9-fold increased in progeny of SAR versus non-SAR vector-modified cells in all hematopoietic lineages for the duration of follow-up (6-12 months). In conclusion, the use of SAR-containing vectors improved transgene expression in hematopoietic repopulating cells, which may obviate the need for multicopy integration to achieve high-level expression and reduce the risk for insertional mutagenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12869503     DOI: 10.1182/blood-2003-03-0962

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

1.  Differential effects of HOXB4 and NUP98-HOXA10hd on hematopoietic repopulating cells in a nonhuman primate model.

Authors:  Korashon L Watts; Xiaobing Zhang; Brian C Beard; Sum Ying Chiu; Grant D Trobridge; R Keith Humphries; Hans-Peter Kiem
Journal:  Hum Gene Ther       Date:  2011-09-06       Impact factor: 5.695

2.  Hematopoietic stem-cell behavior in nonhuman primates.

Authors:  Bryan E Shepherd; Hans-Peter Kiem; Peter M Lansdorp; Cynthia E Dunbar; Geraldine Aubert; Andre LaRochelle; Ruth Seggewiss; Peter Guttorp; Janis L Abkowitz
Journal:  Blood       Date:  2007-05-25       Impact factor: 22.113

Review 3.  Current advances in retroviral gene therapy.

Authors:  Youngsuk Yi; Moon Jong Noh; Kwan Hee Lee
Journal:  Curr Gene Ther       Date:  2011-06       Impact factor: 4.391

4.  Differential effects of HOXB4 on nonhuman primate short- and long-term repopulating cells.

Authors:  Xiao-Bing Zhang; Brian C Beard; Katherine Beebe; Barry Storer; R Keith Humphries; Hans-Peter Kiem
Journal:  PLoS Med       Date:  2006-05-02       Impact factor: 11.069

5.  Matrix attachment regions as targets for retroviral integration.

Authors:  Chassidy N Johnson; Laura S Levy
Journal:  Virol J       Date:  2005-08-19       Impact factor: 4.099

6.  A Rapamycin-Activated Caspase 9-Based Suicide Gene.

Authors:  Maria Stavrou; Brian Philip; Charlotte Traynor-White; Christopher G Davis; Shimobi Onuoha; Shaun Cordoba; Simon Thomas; Martin Pule
Journal:  Mol Ther       Date:  2018-03-09       Impact factor: 11.454

7.  S/MAR sequence confers long-term mitotic stability on non-integrating lentiviral vector episomes without selection.

Authors:  Santhosh Chakkaramakkil Verghese; Natalya A Goloviznina; Amy M Skinner; Hans J Lipps; Peter Kurre
Journal:  Nucleic Acids Res       Date:  2014-01-27       Impact factor: 16.971

8.  An Optimized GD2-Targeting Retroviral Cassette for More Potent and Safer Cellular Therapy of Neuroblastoma and Other Cancers.

Authors:  Simon Thomas; Karin Straathof; Nourredine Himoudi; John Anderson; Martin Pule
Journal:  PLoS One       Date:  2016-03-31       Impact factor: 3.240

9.  Shortened nuclear matrix attachment regions are sufficient for replication and maintenance of episomes in mammalian cells.

Authors:  Xiao-Yin Wang; Xi Zhang; Tian-Yun Wang; Yan-Long Jia; Dan-Hua Xu; Dan-Dan Yi
Journal:  Mol Biol Cell       Date:  2019-09-11       Impact factor: 4.138

10.  Combined Antiviral Therapy Using Designed Molecular Scaffolds Targeting Two Distinct Viral Functions, HIV-1 Genome Integration and Capsid Assembly.

Authors:  Wannisa Khamaikawin; Somphot Saoin; Sawitree Nangola; Koollawat Chupradit; Supachai Sakkhachornphop; Sudarat Hadpech; Nattawat Onlamoon; Aftab A Ansari; Siddappa N Byrareddy; Pierre Boulanger; Saw-See Hong; Bruce E Torbett; Chatchai Tayapiwatana
Journal:  Mol Ther Nucleic Acids       Date:  2015-08-25       Impact factor: 10.183

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.